Home › Neuroscience › Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Neuroscience JoVE (Open Access) Citable · DOI

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

DOI: 10.3791/56410-v
What you'll learn
  • ✓ Prepare micro-osmotic pump infusion systems for brain delivery
  • ✓ Perform intracerebral ventricular surgery to implant the pump
  • ✓ Conduct OGTT and ITT to assess glucose metabolism
  • ✓ Interpret hypothalamic insulin signaling and glucose intolerance
Protocol

Biopharma Insights This protocol studies the role of chemokine (C-C motif) ligand 5 (CCL5) in the hypothalamus by delivering an antagonist, MetCCL5, into the mouse brain using a micro-osmotic pump brain infusion system. This transient inhibition of CCL5 activity interrupted hypothalamic insulin signaling, leading to glucose intolerance and peripheral systemic insulin sensitivity.

Difficulty
advanced
Total time
~2 hrs/surgery + 1 week recovery + 3 hrs testing
Model organism
Mouse C57BL/6J
Biosafety
BSL-1

Steps

1
Prepare micro-osmotic pump infusion systems

Assemble and fill micro-osmotic pumps with MetCCL5 antagonist or vehicle for continuous brain infusion.

▶ 01:21
2
Implant micro-osmotic pump intracerebroventricularly

Perform stereotaxic surgery to cannulate the lateral ventricle and implant the pump subcutaneously.

▶ 02:41
3
Perform OGTT and ITT

Administer oral glucose or intraperitoneal insulin and measure blood glucose over time.

▶ 04:15
4
Analyze glucose metabolism and insulin signaling

Assess glucose tolerance, insulin sensitivity, and hypothalamic insulin signal activation.

▶ 06:04
5
Conclude hypothalamic CCL5 role in glucose homeostasis

Summarize how transient CCL5 inhibition impairs hypothalamic insulin signaling and peripheral glucose tolerance.

▶ 07:27
💬 Comments coming soon